Furthermore, Lang et al. (2019) reported that IFN-γ derived from immunotherapy-activated CD8+ T cells combined with radiotherapy-activated ataxia-telangiectasia mutated (ATM) can strengthen ferroptosis in fibrosarcoma and melanoma cells, which underpins the crosstalk between ferroptosis and anticancer immunity. Here, CD8A is linked to fibrosarcoma.